Home  >  TopNews
Eppen_CellXpert_Feb25
Waters_Ebook_Dec24
you can get e-magazine links on WhatsApp. Click here
Research + Font Resize -

Indian life sciences sector integrating technologies in R&D efforts

Nandita Vijayasimha, Bengaluru
Saturday, July 27, 2024, 08:00 Hrs  [IST]

The Indian life sciences sector is making strides by integrating quantum computing, artificial intelligence (AI), machine learning (ML), advanced analytics, big data, internet of things (IoT) and blockchain into their research and development efforts.
 
With the recent Union Budget 2024-25 providing a renewed focus on innovation and R&D, industry experts note that it will transform India into a value-driven economy, unleashing its immense potential.
 
The country’s life sciences R&D is at a cusp of a major transformation. It is driven by technological advancements, collaborations, regulatory reforms, investment in startups, focus on affordable healthcare, global market expansion and research excellence.
 
Quantum computing has the potential to revolutionize drug discovery by simulating molecular interactions at unprecedented speeds. This can lead to faster identification of promising drug candidates and more efficient development processes, said Dr Subrahmanyam Vangala, CEO, Reagene Bioscience.
 
Saransh Chaudhary, president, global critical care, Venus Remedies and CEO, Venus Medicine Research Centre said inclusion of manufacturing, services, innovation, research & development among the nine priority areas identified by the government will ensure fast-paced growth in line with its vision of ‘Viksit Bharat’. A renewed focus on innovation and R&D, on the other hand, will transform India into a value-driven economy, unleashing its immense potential wealth creation potential.
 
Overall, the life sciences R&D landscape in India is evolving rapidly, driven by innovation, collaboration, and a conducive regulatory environment. This transformation holds promise for addressing global healthcare challenges and positioning India as a key player in the global life sciences arena, said Dr Taslimarif Saiyed, director-CEO, C-CAMP,(Centre for Cellular and Molecular Platform), Bengaluru.
 
Noting that R&D is integral to drive future business growth, Kiran Mazumdar-Shaw, chairperson, Biocon & Biocon Biologics, said, “We will continue to invest in R&D across all our business segments. Biocon is the front runner in the space of green chemistry on the back of its four decades of experience in fermentation technology, biotransformation and bio-catalysis.”
 
The rapid integration of technologies such as are seen to accelerate the pace of R&D. Particularly, analytics is revolutionizing R&D processes, aiding to enhance drug discovery, clinical trials, and personalized medicine initiatives, said Dr Vangala.
 
Predictive Analytics too helps to analyze vast amounts of biological data to predict disease outbreaks, identify potential therapeutic targets, and optimize treatment protocols. Here researchers from the National Centre for Biological Research, Bengaluru said that there is a need to understand the biology of the disease and focus on targeted drug development. Technology advancements such as drug discovery software are significantly reducing the time taken for drug development. Virtual Screening Software can simulate the interactions between potential drugs and biological targets, identifying promising candidates more quickly than traditional methods.
 
Maximising these technologies can spur innovation in drug development, diagnostics, and personalized medicine. Moreover by advancing in these areas, Indian life sciences can enhance their global competitiveness and contribute significantly to international research and development.

 

*POST YOUR COMMENT
Comments
* Name :     
* Email :    
  Website :  
   
     
 
Avians_2025
Asia_Lab_Expo2025
chemexpoindia
ana-Lab-India_25
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram